Biodesix Inc (BDSX) — Strategic Asset Allocation Index
Biodesix Inc (BDSX) has a Strategic Asset Allocation Index of 42.8% as of December 2022. Strategic assets (PP&E of $8.82 Million plus long-term investments of $-) total $8.82 Million, measured against net assets of $20.61 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Biodesix Inc Strategic Asset Allocation Index (2020–2022)
This chart shows how Biodesix Inc's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of December 2022, the index stands at 42.8%, representing strategic assets of $8.82 Million against net assets of $20.61 Million USD. Explore BDSX cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Biodesix Inc (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Biodesix Inc from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of Biodesix Inc.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 42.8% | $8.82 Million | $8.82 Million | $- | $20.61 Million | ▲ +21.6 pp |
| 2021 | 21.2% | $4.18 Million | $4.18 Million | $- | $19.73 Million | ▲ +13.5 pp |
| 2020 | 7.7% | $3.18 Million | $3.18 Million | $- | $41.17 Million | — |